Transplacental cocaine exposure 3: Mechanisms underlying altered brain development

Neurotoxicology and Teratology

Volumn 20, Issue 3, 1998, Pages 239-249

  Wilkins, Aaron S ^a   Marota, John J A ^a   Tabit, Eddy ^a   Kosofsky, Barry E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Behavioral teratology; Brain development; Monoamines; Mouse model; Prenatal cocaine; Prenatal malnutrition

Indexed keywords

COCAINE; PHENTOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR DISORDER; BEHAVIOR TERATOLOGY; BRAIN GROWTH; CONDITIONING; CONTROLLED STUDY; FEMALE; GROWTH RETARDATION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NEWBORN; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; VASOCONSTRICTION;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; COCAINE; CONDITIONING (PSYCHOLOGY); EMBRYONIC AND FETAL DEVELOPMENT; FEEDING BEHAVIOR; FEMALE; MALE; MATERNAL-FETAL EXCHANGE; MICE; PLACENTA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; WEIGHT GAIN;

EID: 0031745009     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0892-0362(97)00128-1     Document Type: Article

References (40)

1. Anderson-Brown, T.; Slotkin, T. A.; Seidler, F. J.: Cocaine acutely inhibits DNA synthesis in developing rat brain regions: Evidence for direct actions. Brain Res. 537:197-202; 1990.
2. Barnett, G.; Hawks, R.; Resnick, R.: Cocaine pharmacokinetics in humans. J. Ethnopharmacol. 3:353-366; 1981.
3. Burchfield, D. J.; Graham, E. M.; Abrams, R. M.; Gerhardt, K. J.: Cocaine alters behavioral states in fetal sheep. Dev. Brain Res. 56:41-45; 1990.
4. Church, M. W.; Overbeck, G. W.: Prenatal cocaine exposure in the Long-Evans rat: II. Dose-dependent effects on offspring behavior. Neurotoxicol. Teratol. 12:335-343; 1990.
5. Crider, A.; Blockel, L.; Solomon, P. R.: A selective attention deficit in the rat following induced dopamine receptor supersensitivity. Behav. Neurosci. 100:315-319; 1986.
6. 1 receptor blockade upon maternal and fetal cardiovascular responses to cocaine. Obstet. Gynecol. 75:745-751; 1990.
7. Dow-Edwards, D.; Fico, T. A.; Osman, M.; Gamagaris, Z.; Hutchings, D. E.: Comparison of oral and SC routes of cocaine administration on behavior, plasma drug concentration and toxicity in female rats. Pharmacol. Biochem. Behav. 33:167-173; 1989.
8. Dow-Edwards, D.: Cocaine effects on fetal development: A comparison of clinical and animal research findings. Neurotoxicol. Teratol. 13:347-352; 1991.
9. Fantel, A. G.; Barber, C. V.; Mackler, B.: Ischemia/reperfusion: A new hypothesis for the developmental toxicity of cocaine. Teratology 46:285-292; 1992.
10. Gingras, J. L.; Weese-Mayer, D. E.; Hume, R. F., Jr.; O'Donnell, K. J.: Cocaine and development: Mechanisms of fetal toxicity and neonatal consequences of prenatal cocaine exposure. Early Hum. Dev. 31:1-24; 1992.
11. Gressens, P.; Gofflot, F.; Van Maele-Fabry, G.; Misson, J. P.; Gadisseux, J. F.; Evrard, P.; Picard, J. J.: Early neurogenesis and teratogenesis in whole mouse embryo cultures. Histochemical, immunocytological and ultrastructural study of the premigratory neuronal-glial units in normal mouse embryo and in mouse embryos influenced by cocaine and retinoic acid. J. Neuropathol. Exp. Neurol. 51:206-219; 1992.
12. Hieble, J. P.; Nichols, A. J.; Langer, S. Z.; Ruffolo, R. R., Jr.: Pharmacology of the sympathetic nervous system. In: Munson, P. L.; Mueller, R. A.; Breese, G. R., eds. Principles of pharmacology. New York: Chapman and Hall; 1995:121-144.
13. Horsman, M. R.; Christensen, K. L.; Overgaard, J.: Importance of nicotinamide dose on blood pressure changes in mice and humans. Int. J. Radiat. Oncol. Biol. Phys. 29:455-458; 1994.
14. Hoyme, H. E.; Jones, K. L.; Dixon, S. D.; Jewett, T.; Hanson, J. W.; Robinson, L. K.; Msall, M. E.; Allanson, J. E.: Prenatal cocaine exposure and fetal vascular disruption. Pediatrics 85:743-747; 1990.
15. Jones, L.; Fischer, I.; Levitt, P.: Nonuniform alteration of dendritic development in the cerebral cortex following prenatal cocaine exposure. Cereb. Cort. 6:431-445; 1996.
16. Knuepfer, M. M.; Branch, C. A.: Cardiovascular responses to cocaine are initially mediated by the central nervous system in rats. J. Pharmacol. Exp. Ther. 263:734-741; 1992.
17. Koegler, S. M.; Seidler, F. J.; Spencer, J. R.; Slotkin, T. A.: Ischemia contributes to adverse effects of cocaine on brain development: Suppression of ornithine decarboxylase activity in neonatal rat. Brain Res. Bull. 27:829-834; 1991.
18. Konkol, R. J.; Murphey, L. J.; Ferriero, D. M.; Dempsey, D. A.; Olsen, G. D.: Cocaine metabolites in the neonate: Potential for toxicity. J. Child Neurol. 9:242-248; 1994.
19. Kosofsky, B. E.: The effect of cocaine on developing human brain. In: Kilbey, M. M.; Asghar, K., eds. Methodologic issues in controlled studies on effects of prenatal exposure to drugs of abuse. Washington, DC: NIDA Research Monograph #114; 1991:128-143.
20. Kosofsky, B. E.; Hyman, S. E.: The ontogeny of immediate early gene response to cocaine: A molecular analysis of the effects of cocaine on developing brain. In: Grazanna, R. G.; Brown, R. M., eds. Immediate early gene activation by drugs of abuse. Washington, DC: NIDA Research Monograph #125; 1993:161-171.
21. Kosofsky, B. E.; Wilkins, A. S.; Gressens, P.; Evrard, P.: Transplacental cocaine exposure: A mouse model demonstrating neuroanatomic and behavioral abnormalities. J. Child Neurol. 9:234-241; 1994.
22. Lauder, J. M.: Neurotransmitters as growth regulatory signals: Role of receptors and second messages. Trends Neurosci. 16:233-240; 1993.
23. Lidow, M. S.: Prenatal cocaine exposure adversely affects development of the primate cerebral cortex. Synapse 21:332-341; 1995.
24. Moore, T. R.; Sorg, J.; Miller, L.; Key, T. C.; Resnik, R.: Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus. Am. J. Obstet. Gynecol. 155:883-888; 1986.
25. Muir, J. K.; Ellis, E. F.: Cocaine potentiates the blood pressure and cerebral blood flow response to norepinephrine in rats. Eur. J. Pharmacol. 249:287-292; 1993.
26. Murphy, E. H.; Hammer, J. G.; Schumann, M. D.; Groce, M. Y.; Wang, X-H.; Jones, L.; Romano, A. G.; Harvey, J. A.: The rabbit as a model for studies of in utero cocaine exposure. Lab. Anim. Sci. 45:163-168; 1995.
27. Nelson, S. H.; Steinsland, O. S.; Suresh, M. S.: Possible physiological role of calcitonin gene-related peptide in the human uterine artery. Am. J. Obstet. Gynecol. 168:605-611; 1993.
28. + channels in the human uterine artery. Eur. J. Pharmacol. 242:255-261; 1993.
29. Posner, M. I.; Peterson, S. E.: The attention system of the human brain. Annu. Rev. Neurosci. 13:25-42; 1990.
30. Ronnekleiv, O. K.; Naylor, B. R.: Chronic cocaine exposure in the fetal rhesus monkey: Consequences for early development of dopamine neurons. J. Neurosci. 15:7330-7343; 1995.
31. Seidler, F. J.; Temple, S. W.; McCook, E. C.; Slotkin, T. A.: Cocaine inhibits central noradrenergic and dopaminergic activity during the critical developmental period in which catacholamines influence cell development. Dev. Brain Res. 85:48-53; 1995.
32. 3H] cocaine in pregnant and nonpregnant mice. Toxicol. Appl. Pharmacol. 53:279-284; 1980.
33. Spear, L. P.: Missing pieces of the puzzle complicate conclusions about cocaine's neurobehavioral toxicity in clinical populations: Importance of animal models. Neurotoxicol. Teratol. 15:307-309; 1993.
34. Spear, L. P.; Frambes, N. A.; Kirstein, C. L.: Fetal and maternal brain and plasma levels of cocaine and benzoylecgonine following chronic subcutaneous administration of cocaine during gestation in rats. Psychopharmacology (Berlin) 97:427-431; 1989.
35. Tella, S. R.; Schindler, C. W.; Goldberg, S. R.: Cardiovascular effects of cocaine in conscious rats: Relative significance of central sympathetic stimulation and peripheral neuronal monoamine uptake and release mechanisms. J. Pharmacol. Exp. Ther. 262: 602-610; 1992.
36. Thadani, P. V.: Biological mechanisms and perinatal exposure to abused drugs. Synapse 19:228-232; 1995.
37. Volpe, J. J.: Effect of cocaine use on the fetus. N. Engl. J. Med. 327:399-407; 1992.
38. Wilkins, A. S.; Genova, L. M.; Posten, W.; Kosofsky, B. E.: Transplacental cocaine exposure 1: A rodent model. Neurotoxicol. Teratol. 20:215-226; 1998.
39. Wilkins, A. S.; Jones, K.; Kosofsky, B. E.: Transplacental cocaine exposure 2: Effects of cocaine dose and gestational timing. Neurotoxicol. Teratol. 20:227-238; 1998.
40. Woods, J. R.; Plessinger, M. A.; Clark, K. E.: Effect of cocaine on uterine blood flow and fetal oxygenation. J. Am. Med. Assoc. 257:957-961; 1987.